Cargando…
The monoclonal antibody SM5-1 recognizes a fibronectin variant which is widely expressed in melanoma
BACKGROUND: Previously we have generated the monoclonal antibody SM5-1 by using a subtractive immunization protocol of human melanoma. This antibody exhibits a high sensitivity for primary melanomas of 99% (248/250 tested) and for metastatic melanoma of 96% (146/151 tested) in paraffin embedded sect...
Autores principales: | Trefzer, Uwe, Chen, Yingwen, Herberth, Gunda, Hofmann, Maja Ann, Kiecker, Felix, Guo, Yajun, Sterry, Wolfram |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central,
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1351261/ https://www.ncbi.nlm.nih.gov/pubmed/16405722 http://dx.doi.org/10.1186/1471-2407-6-8 |
Ejemplares similares
-
Long-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report
por: Jochmann, Nicoline, et al.
Publicado: (2005) -
Proteome Serological Determination of Tumor-Associated Antigens in Melanoma
por: Forgber, Michael, et al.
Publicado: (2009) -
Remission of an Intracardiac Melanoma Metastasis after Tremelimumab Therapy
por: Spethmann, Sebastian, et al.
Publicado: (2014) -
Small Molecules Antagonise the MIA-Fibronectin Interaction in Malignant Melanoma
por: Yip, King Tuo, et al.
Publicado: (2016) -
Fibronectin receptor of human macrophages recognizes the sequence Arg- Gly-Asp-Ser
Publicado: (1985)